CIK 0001870404 · <br>Emerging growth company
CERO THERAPEUTICS HOLDINGS, INC.
Sign in to watch- Tickers
- CERO CEROW
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 871088814
- Phone
- 650-407-2376
- Business address
- 201 HASKINS WAY, SUITE 230, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- CERO THERAPEUTICS HOLDINGS, INC., PHOENIX BIOTECH ACQUISITION CORP.
Securities
- CERO Common stock OTC
- CEROW Common stock OTC
- 8-K Event Results of operations · Executive or director change · Regulation FD disclosure
- 3 Insider Initial Statement of Ownership
- 424B3 Offering Prospectus
- 424B3 Offering Prospectus
- D Other Notice of Sales of Unregistered Securities
- 4 Option exercise Director acquired 965,997 shares (option exercise)
- 4 Option exercise Interim Chairman and CEO acquired 5,312,983 shares (option exercise)
- 4 Option exercise Director acquired 19,358,578 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- PRE 14A Proxy Proxy Statement (Preliminary)
- 8-K Event Executive or director change · Other events
- 8-K Event Bylaws or fiscal year change · Other events
- 424B3 Offering Prospectus
- 8-K Event Other events
- 424B3 Offering Prospectus
- 8-K Event Material agreement · Unregistered share sale · Executive or director change · Other events
- 8-K Event Executive or director change
Page 13 of 23 · 445 filings